Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Potassium voltage-gated channel subfamily C member 1 (KCNC1), also known as Kv3.1, is an integral membrane protein that functions as a voltage-gated potassium channel. It mediates the voltage-dependent permeability of potassium ions across excitable membranes, playing a crucial role in repolarizing the membrane potential after action potentials. Kv3.1 channels are predominantly expressed in neurons that fire at high frequency, and are essential for enabling high-frequency action potential generation. Variants or dysfunctions in KCNC1 have been associated with neurological disorders due to its critical role in neuronal excitability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium voltage-gated channel subfamily C member 1 (Kv3.1).